Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

New research shows calves fed waste milk develop different immune cell and cytokine profiles than those fed salable milk, ...

Janux Therapeutics develops intratumoral immuno-oncology therapies as nasdaq 100 index discussions highlight biotech ...

SEATTLE, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune ...

Brazil's 110+ year-olds have exceptional immune cells, protective genes, and families where extreme longevity runs across ...

An immunologist imagines the body’s defense system as a team of unique, quirky characters, showcasing their essential roles.

Adaptive Biotechnologies ( ($ADPT) ) has issued an announcement. On December 30, 2025, Adaptive Biotechnologies announced that its 70%-owned ...

The collaboration leverages BostonGene's foundation model for tumor and immune biology to deliver predictive insights on patient-level safety and efficacy outcomes in early clinical trials.

Overview: AI cybersecurity uses machine learning and automation to detect threats in real time.Leading firms in the USA are ...

"David brings to Indaptus significant expertise, and I look forward to working with him to evaluate the ongoing business, identify business opportunities for the Decoy platform, and seek strategic ...

Americans have the right to make their own health care choices, including making their own decisions regarding vaccines and whatever purported disease or illness-prevention measures they wish to ...